Biocon (NSE:BIOCON) Beginning Cash Position : ₹0 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Biocon Beginning Cash Position?

Biocon's Beginning Cash Position for the quarter that ended in Mar. 2024 was ₹0 Mil.

Biocon's annual Beginning Cash Position declined from Mar. 2022 (₹9,308 Mil) to Mar. 2023 (₹6,537 Mil) but then increased from Mar. 2023 (₹6,537 Mil) to Mar. 2024 (₹12,999 Mil).

Biocon Beginning Cash Position Historical Data

The historical data trend for Biocon's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocon Beginning Cash Position Chart

Biocon Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Beginning Cash Position

Get a 7-Day Free Trial

6,593.00

7,909.00

9,308.00

6,537.00

12,999.00

Biocon Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

Biocon Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Biocon Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Biocon's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocon (NSE:BIOCON) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (NSE:BIOCON) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

532523:India

Address

20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560 100

Website

https://www.biocon.com

Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Generics, Biosimilars, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene.

Biocon (NSE:BIOCON) Headlines

No Headlines